Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Creatine Monohydrate Supplementation in Depressed Female Methamphetamine Users

NCT02189915 is registered in ClinicalTrials.gov with Perry Renshaw as lead sponsor.

NCT NCT02189915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02189915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Creatine Monohydrate Supplementation in Depressed Female Methamphetamine Users
Lead sponsor
Perry Renshaw
Phase
Not applicable
Overall status
Terminated
Start date
January 31, 2012
Completion date
October 31, 2015
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, dual diagnosis, substance use